RESUMEN
Background: Prolonged warm ischemia time (WIT) in kidney transplantation is associated with numerous adverse outcomes including delayed graft function and decreased patient and graft survival. Circumventing WIT lies in maintaining renal hypothermia and efficiently performing the vascular anastomosis during this portion of the procedure. Although numerous methods of intra-operative renal cooling have been proposed, most suffer from practical limitations, and none have been widely adopted. Herein we describe a novel device specifically designed to maintain renal hypothermia during kidney transplant surgery.Methods: Aluminum tubing was organized in a serpentine pattern to create a malleable, form-fitting cooling jacket to manipulate renal allografts during transplant surgery. Adult porcine kidneys were used to test the device with 4°C saline as coolant. Kidneys were placed at 24°C; surface and core temperatures were monitored using implanted thermocouples. Anastomosis of porcine kidney vessels to GORE-TEX® vascular grafts in an ex-vivo operative field was performed to assess the functionality of the device.Results: The device maintained surface and core graft temperatures of ≤5°C after 60 minutes of WIT. Furthermore, the device provided hands-free retraction and support for the allograft. We found that ex-vivo anastomosis testing was enhanced by the presence of the cooling jacket.Conclusions: This proof-of-concept study demonstrated that our novel device is a practical tool for renal transplantation and can maintain sufficiently cool graft temperatures to mitigate WIT in an ex-vivo setting. This device is the first of its kind and has the potential to improve kidney transplant outcomes by eliminating WIT during graft implantation.
Asunto(s)
Trasplante de Riñón , Trasplante de Riñón/instrumentación , Porcinos , Animales , Hipotermia Inducida/instrumentación , Hipotermia Inducida/métodos , Diseño de Equipo , Isquemia Tibia , Riñón/cirugíaRESUMEN
INTRODUCTION: In patients requiring both hemodialysis (HD) and apheresis, the 2 treatments can be performed simultaneously. At our hospital, selective plasma exchange (SePE) is often performed along with HD for removal of isoagglutinins before ABO-incompatible (ABOi) kidney transplantation. The 2 treatments can be completed within the HD schedule, which allows the treatment time to be shortened. This approach is also less stressful for patients because fewer punctures are required. In this study, we investigated the safety and efficacy of tandem HD and SePE. METHODS: A total of 58 SePE sessions in 30 ABOi kidney transplant recipients were investigated. The SePE circuit was connected in parallel with the HD circuit, and tandem HD and SePE therapy was performed using filtration methods. The SePE sessions were divided into 2 groups: those with SePE monotherapy (group S, n = 20) and those with tandem therapy (group T, n = 38). Changes in transmembrane pressure (TMP), arterial pressure (AP), venous pressure (VP), and decrease in isoagglutinin titers over time were compared between the groups with adjustment for background data. RESULTS: The internal pressures (AP and VP) were higher in group T, and there were significant differences in changes of TMP and AP over time between groups T and S. Membrane exchange was required in 1 case in group T due to coagulation. There was a more significant decrease of immunoglobulin G isoagglutinin titers in group T compared to group S. No case had antibody-mediated rejection after transplantation. DISCUSSION/CONCLUSION: In HD/SePE tandem therapy, internal pressures were higher and TMP and AP tended to increase more compared to SePE monotherapy, but we were able to perform the 2 treatments without any functional problems. Tandem therapy was also effective in decreasing isoagglutinin titers, which suggests that this may be a beneficial treatment modality as apheresis before ABOi kidney transplantation.
Asunto(s)
Trasplante de Riñón/métodos , Intercambio Plasmático/métodos , Diálisis Renal/métodos , Sistema del Grupo Sanguíneo ABO/inmunología , Diseño de Equipo , Rechazo de Injerto/etiología , Rechazo de Injerto/inmunología , Supervivencia de Injerto , Humanos , Trasplante de Riñón/efectos adversos , Trasplante de Riñón/instrumentación , Intercambio Plasmático/efectos adversos , Intercambio Plasmático/instrumentación , Diálisis Renal/efectos adversos , Diálisis Renal/instrumentación , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
OBJECTIVES: BK polyomavirus is one of the main causes of chronic renal failure and ureteral stenosis in kidney transplant recipients, affecting approximately 15% of kidney transplant patients during the first year after transplant. The immunosuppressive treatment used in these recipients allows a reactivation of the virus by allowing infection, which can manifest from viruria, viremia, or nephropathy. The use of ureteral stents in renal transplant to prevent postoperative complications has been associated with an increase in BK polyomavirus nephropathy. Our objective was to describe associations between viruria and viremia and our reimplantation surgical technique and ureteral stenting. MATERIALS AND METHODS: We conducted a retrospective review of 184 transplant recipients who were seen at our center between January 2013 and December 2016. To define possible risk factors from analysis of different variables, we categorized patients into 3 groups: patients who did not present with either viremia or viruria caused by BK virus, patients who presented with viremia, and patients who presented with viruria. RESULTS: We found that 127 transplant recipients (69%) presented with neither BK viruria nor BK viremia, 11 recipients (6%) presented with BK viremia, and 46 recipients (25%) presented with BK viruria. No patient in the study had BK polyomavirus nephropathy. CONCLUSIONS: Our type of ureteral stenting has a low rate of BK viruria and BK viremia compared with other studies. In addition, with our technique, the ureteral stent removal procedure does not require an invasive endoscopic procedure, thereby avoiding the consequent economic and assistance inconvenience typically associated with an endoscopic procedure.
Asunto(s)
Virus BK/patogenicidad , Trasplante de Riñón/efectos adversos , Infecciones por Polyomavirus/epidemiología , Infecciones Tumorales por Virus/epidemiología , Uréter/cirugía , Remoción de Dispositivos , Femenino , Humanos , Trasplante de Riñón/instrumentación , Masculino , Persona de Mediana Edad , Infecciones por Polyomavirus/diagnóstico , Infecciones por Polyomavirus/virología , Prevalencia , Reimplantación , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , España , Stents , Resultado del Tratamiento , Infecciones Tumorales por Virus/diagnóstico , Infecciones Tumorales por Virus/virología , Viremia/diagnóstico , Viremia/virología , Activación ViralRESUMEN
INTRODUCTION: We evaluated whether second-generation laryngeal mask airway (LMA) could provide an adequate pulmonary gas exchange during prolonged abdominal surgery compared to endotracheal tube (ETT) using propensity score matching. METHODS: Of the 257 recipients who underwent living donor kidney transplantation (LDKT), the LMA group and ETT group were matched: 87 of 101 recipients who inserted second-generation LMA were matched with 87 of 156 recipients who inserted ETT. Arterial partial pressure of carbon dioxide (PaCO2) and ratio of arterial partial pressure of oxygen to fractional inspired oxygen (PFR) and intraoperative ventilator parameters were compared between the 2 groups. In addition, we compared incidences of postoperative pulmonary and nonpulmonary complications including hoarseness, vocal cord palsy, nausea, vomiting, arrhythmia, and delirium between the 2 groups. RESULTS: Median anesthesia time was 357 minutes. PaCO2 and PFR were comparable between the 2 groups and did not show group and time interaction. Ventilator parameters during surgery were comparable, and incidences of both postoperative pulmonary and nonpulmonary complications were also comparable between the 2 groups. CONCLUSION: Second-generation LMA could provide an adequate pulmonary gas exchange compared with ETT during LDKT. In terms of pulmonary gas exchange, second-generation LMA could be considered as a suitable alternative to ETT during prolonged abdominal surgery.
Asunto(s)
Intubación Intratraqueal , Trasplante de Riñón/instrumentación , Máscaras Laríngeas , Complicaciones Posoperatorias/epidemiología , Intercambio Gaseoso Pulmonar/fisiología , Adulto , Femenino , Humanos , Incidencia , Intubación Intratraqueal/efectos adversos , Máscaras Laríngeas/efectos adversos , Donadores Vivos , Masculino , Complicaciones Posoperatorias/etiología , Puntaje de Propensión , Resultado del TratamientoRESUMEN
With the aim to explore innovative tools for organ preservation, especially in marginal organs, we hereby describe a clinical trial of ex-vivo hypothermic oxygenated perfusion (HOPE) in the field of liver (LT) and kidney transplantation (KT) from Extended Criteria Donors (ECD) after brain death. A matched-case analysis of donor and recipient variables was developed: 10 HOPE-ECD livers and kidneys (HOPE-L and HOPE-K) were matched 1:3 with livers and kidneys preserved with static cold storage (SCS-L and SCS-K). HOPE and SCS groups resulted with similar basal characteristics, both for recipients and donors. Cumulative liver and kidney graft dysfunction were 10% (HOPE L-K) vs. 31.7%, in SCS group (p = 0.05). Primary non-function was 3.3% for SCS-L vs. 0% for HOPE-L. No primary non-function was reported in HOPE-K and SCS-K. Median peak aspartate aminotransferase within 7-days post-LT was significantly higher in SCS-L when compared to HOPE-L (637 vs.344 U/L, p = 0.007). Graft survival at 1-year post-transplant was 93.3% for SCS-L vs. 100% of HOPE-L and 90% for SCS-K vs. 100% of HOPE-K. Clinical outcomes support our hypothesis of machine perfusion being a safe and effective system to reduce ischemic preservation injuries in KT and in LT.
Asunto(s)
Supervivencia de Injerto , Trasplante de Riñón/instrumentación , Trasplante de Hígado/instrumentación , Preservación de Órganos/instrumentación , Perfusión/instrumentación , Donantes de Tejidos , Anciano , Aspartato Aminotransferasas/metabolismo , Frío , Femenino , Humanos , Bombas de Infusión/efectos adversos , Bombas de Infusión/normas , Riñón/metabolismo , Trasplante de Riñón/métodos , Hígado/metabolismo , Trasplante de Hígado/métodos , Masculino , Persona de Mediana Edad , Preservación de Órganos/métodos , Oxigenadores de Membrana/efectos adversos , Oxigenadores de Membrana/normas , Perfusión/métodosRESUMEN
We investigated the feasibility of robotic renal autotransplantation (RAT) in a porcine model to reduce invasiveness of RAT. Five pigs underwent robotic RAT using the da Vinci® robotic system. A robotic left nephrectomy was performed in all cases. Robotic RAT was performed on the left side in all but one case. Four ports were used. In 3 cases, the kidney was taken out through the GelPort® and irrigated on ice with Ringer's solution. In 2 cases, a complete intracorporeal robotic RAT was performed. An end-to-side anastomosis was performed between the renal vein and the external iliac vein and between the renal artery and the external iliac artery. Ureteroneocystostomy was also performed in 2 cases. All cases were performed robotically without open conversion. The median (IQR) console time was 3.1 (0.7) h, and the operative time was 3.8 (1.1) h. The estimated blood loss was 30 (0) ml. The warm ischemia time was 4.0 (0.2) min, and the cold ischemia time was 97 (17) min. Intracorporeal transarterial hypothermic renal perfusion was feasible in the 2 complete intracorporeal robotic RAT cases by using a perfusion catheter through a laparoscopic port. Robotic RAT has the potential to be a new minimally invasive substitute for conventional open surgery.
Asunto(s)
Trasplante de Riñón/instrumentación , Procedimientos Quirúrgicos Robotizados/métodos , Animales , Modelos Animales de Enfermedad , Estudios de Factibilidad , Femenino , Humanos , Laparoscopía/métodos , PorcinosRESUMEN
BACKGROUND: The optimal perfusate partial pressure of oxygen (PO2) during hypothermic machine perfusion (HMP) is unknown. The aims of the study were to determine the functional, metabolic, structural, and flow dynamic effects of low and high perfusate PO2 during continuous HMP in a pig kidney ischemia-reperfusion autotransplant model. METHODS: The left kidneys of a ±40 kg pigs were exposed to 30 minutes of warm ischemia and randomized to receive 22-hour HMP with either low perfusate PO2 (30% oxygen, low oxygenated HMP [HMPO2]) (n = 8) or high perfusate PO2 (90% oxygen, HMPO2high) (n = 8), before autotransplantation. Kidneys stored in 22-hour standard HMP (n = 6) and 22-hour static cold storage (n = 6) conditions served as controls. The follow-up after autotransplantation was 13 days. RESULTS: High PO2 resulted in a 3- and 10-fold increase in perfusate PO2 compared with low HMPO2 and standard HMP, respectively. Both HMPO2 groups were associated with superior graft recovery compared with the control groups. Oxygenation was associated with a more rapid and sustained decrease in renal resistance. While there was no difference in functional outcomes between both HMPO2 groups, there were clear metabolic differences with an inverse correlation between oxygen provision and the concentration of major central metabolites in the perfusion fluid but no differences were observed by oxidative stress and metabolic evaluation on preimplantation biopsies. CONCLUSIONS: While this animal study does not demonstrate any advantages for early graft function for high perfusate PO2, compared with low perfusate PO2, perfusate metabolic profile analysis suggests that aerobic mechanism is better supported under high perfusate PO2 conditions.
Asunto(s)
Hipotermia Inducida/instrumentación , Trasplante de Riñón/instrumentación , Riñón/cirugía , Oxígeno/metabolismo , Perfusión/instrumentación , Animales , Biomarcadores/sangre , Isquemia Fría , Creatinina/sangre , Metabolismo Energético , Diseño de Equipo , Femenino , Hipotermia Inducida/efectos adversos , Riñón/metabolismo , Riñón/patología , Trasplante de Riñón/efectos adversos , Modelos Animales , Presión Parcial , Perfusión/efectos adversos , Distribución Aleatoria , Sus scrofa , Factores de Tiempo , Trasplante Autólogo , Isquemia TibiaRESUMEN
BACKGROUND: With recent advances in surgical technologies, minimally invasive endoscopic and robot-assisted surgical procedures have been introduced. However, prolonged warm ischemic time of the kidneys remains a concern after the organ is removed from a donor and during transplantation into a recipient. We developed a Thermal Barrier Bag (TBB) to prevent warm ischemia during transplantation. To confirm the effectiveness of the TBB, adenosine triphosphate (ATP) activity in the kidney was measured during an ex vivo warming test. An ischemia model porcine kidney was also used as the donor kidney and placed into the TBB; thereafter, the change in temperature at the time of transplantation was examined. MAIN FINDINGS: The purse-like design of the TBB efficiently suppressed heat conduction. A simulation was conducted that allowed the calculation of organ heat transfer condition. In the ex vivo experiment, temperature increases were suppressed in the group whose kidneys were placed in the TBB (30 minutes after transplantation: with TBB = 30°C, without TBB = 35°C). ATP measurements showed that the residual rate was substantially higher in the TBB group (P = .056). Moreover, a temperature suppression effect was demonstrated during the renal transplantation experiment (30 minutes after transplantation: with TBB = 27°C, without TBB = 31°C). CONCLUSION: The ex vivo warming experiment demonstrated that use of TBB slows down the rate of ATP decay in fresh kidneys. In addition, when an ischemic model porcine kidney was placed into the TBB and the temperature change at the time of transplantation was measured, an in vivo temperature-suppressing effect was observed.
Asunto(s)
Isquemia/prevención & control , Trasplante de Riñón/instrumentación , Trasplante de Riñón/métodos , Isquemia Tibia , Adenosina Trifosfato/análisis , Animales , Modelos Animales , PorcinosRESUMEN
OBJECTIVES: Ureteral complications remain a major source of morbidity and occasional mortality in renal transplant. Among all ureteral complications, leaks are the most frequently encountered in the early posttransplant period. The routine use of a double-J ureteric stent remains controversial, with reported increased incidence of urinary tract infection. Here, we retrospectively compared the efficacy of a double J stent in kidney transplant patients to investigate ureteral complication incidence in our center. MATERIALS AND METHODS: Our study included 382 kidney transplant patients. At 5 weeks after transplant, the double J stent was removed under sedation. Patients were divided into 2 groups: 125 patients with double J stent placement (group 1) and 257 patients without double J stent placement (group 2). RESULTS: We observed no significant demographic differences between the 2 groups with regard to patient age (median patient age of 30 y [range, 2-73 y] for group 1; median patient age of 33 y [range, 4-69 y] for group 2), patient sex (30.2% females in group 1, 32.4% females in group 2), and body mass index (median of 25.1 vs 24.9 kg/m2 in groups 1 and 2, respectively). Cold and warm ischemia time for donor organ, delayed graft function, and episodes of acute rejection did not differ significantly between the groups. Urinary tract infection was observed in 25/125 (20.4%) and 50/257 patients (19.2%) in groups 1 and 2, respectively. Urinary leak was present in 8/125 group 1 (6.4%) and 6/257 group 2 patients (2.3%). CONCLUSIONS: A double J stent in ureteral anastomosis was not likely to decrease the frequency of leakage but is likely to reduce the gravity of the complication and the need for reoperation. In addition, the use of a double J stent was not associated with increased urinary tract infections in renal transplant recipients.
Asunto(s)
Hematuria/epidemiología , Trasplante de Riñón/instrumentación , Stents , Obstrucción Uretral/epidemiología , Incontinencia Urinaria/epidemiología , Infecciones Urinarias/epidemiología , Adolescente , Adulto , Anciano , Niño , Preescolar , Femenino , Hematuria/diagnóstico , Humanos , Incidencia , Trasplante de Riñón/efectos adversos , Masculino , Persona de Mediana Edad , Diseño de Prótesis , Estudios Retrospectivos , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento , Turquía/epidemiología , Obstrucción Uretral/diagnóstico , Incontinencia Urinaria/diagnóstico , Infecciones Urinarias/diagnóstico , Infecciones Urinarias/microbiología , Adulto JovenRESUMEN
Transportable normothermic kidney perfusion for 24 hours or longer could enable viability assessment of marginal grafts, increased organ use, and improved transplant logistics. Eleven clinically declined kidneys were perfused normothermically, with 6 being from donors after brain death (median cold ischemia time 33 ± 36.9 hours) and 5 being from donors after circulatory death (36.2 ± 38.3 hours). Three kidneys were perfused using Ringer's lactate to replace excreted urine volume, and 8 kidneys were perfused using urine recirculation to maintain perfusate volume without fluid replenishment. In all cases, normothermic perfusion either maintained or slightly improved the histopathologically assessed tubular condition, and there was effective urine production in kidneys from both donors after brain death and donors after circulatory death (2367 ± 1798 mL vs 744.4 ± 198.4 mL, respectively; P = .44). Biomarkers, neutrophil gelatinase-associated lipocalin, and kidney injury molecule-1 were successfully detected and quantified in the perfusate. All kidneys with urine recirculation were readily perfused for 24 hours (n = 8) and exhibited physiological perfusate sodium levels (140.7 ± 1.2 mmol/L), while kidneys without urine recirculation (n = 3) achieved a reduced normothermic perfusion time of 7.7 ± 1.5 hours and significantly higher perfusate sodium levels (159.6 ± 4.63 mmol/:, P < .01). Normothermic machine perfusion of human kidneys for 24 hours appears to be feasible, and urine recirculation was found to facilitate the maintenance of perfusate volume and homeostasis.
Asunto(s)
Trasplante de Riñón/métodos , Riñón/cirugía , Preservación de Órganos/métodos , Perfusión , Orina , Anciano , Biomarcadores/orina , Isquemia Fría , Femenino , Glucosa/análisis , Hemodinámica , Humanos , Trasplante de Riñón/instrumentación , Ácido Láctico/análisis , Lipocalina 2/análisis , Masculino , Persona de Mediana Edad , Preservación de Órganos/instrumentaciónRESUMEN
OBJECTIVE: To report the development of the first robot-assisted kidney transplantation (RAKT) programme from deceased donors, examining technical feasibility and early perioperative and functional outcomes at a referral academic centre. PATIENTS AND METHODS: A RAKT programme was developed in 2016 at our institution following structured modular training. Specific inclusion/exclusion criteria for both living and deceased donors were set. Data from patients undergoing RAKT from January 2017 to April 2018 were prospectively collected in an a priori developed web-based data set. RAKT followed the principles of the Vattikuti Urology Institute-Medanta technique, with specific technical modifications based on clinical recipient characteristics, as well as surgeon's skills and preference during the learning curve. Technical feasibility of RAKT from deceased donors and evaluation of perioperative and early functional outcomes were the main study endpoints. RESULTS: In all, 17 RAKTs were performed during the study period. Of these, six were from living donors and 11 were from deceased donors. All RAKTs were successfully completed without need of conversion. The median (interquartile range [IQR]) console time was 190 (160-220) min and the median (IQR) estimated blood loss was 120 (110-140) mL. The median times to complete venous, arterial and uretero-vesical anastomoses were 21, 22 and 21 min, respectively. The median (IQR) length of stay was 8 (6-12) days. At a median (IQR) follow-up of 8 (6-11) months, five (30%) complications were recorded. Of these, four (24%) were minor (Clavien-Dindo Grade I-II) and one major (Clavien-Dindo Grade IIIb, requiring graft nephrectomy). Overall, two patients were still on dialysis at last follow-up. A significant improvement in graft function was recorded progressively at all postoperative time points. CONCLUSION: Our preliminary experience outlines that: (i) the development of a RAKT programme is feasible in centres experienced in robotic surgery and open kidney transplantation; (ii) RAKT from deceased donors is feasible from both a technical and logistical perspective; and (iii) RAKT from deceased donors appears to achieve favourable early postoperative and functional outcomes. Larger studies with longer follow-up are needed to confirm these findings and compare the outcomes of RAKT from deceased donors with those from living donors.
Asunto(s)
Supervivencia de Injerto/fisiología , Trasplante de Riñón/instrumentación , Reperfusión/métodos , Procedimientos Quirúrgicos Robotizados , Adulto , Estudios de Factibilidad , Femenino , Humanos , Trasplante de Riñón/métodos , Trasplante de Riñón/tendencias , Masculino , Persona de Mediana Edad , Monitoreo Intraoperatorio , Tempo Operativo , Desarrollo de Programa , Evaluación de Programas y Proyectos de Salud , Estudios Prospectivos , Resultado del TratamientoRESUMEN
BACKGROUND: In patients undergoing kidney transplantation, ureteral stents are an established technique to reduce major urologic complications such as leakage and stenosis of the ureter. However, the best technique for ureteral stenting remains unclear. The aim of this study was to compare the outcome of percutaneous ureteral stents (PS) with internal double J stents (JJS) after kidney transplantation. METHODS: All patients undergoing kidney transplantation between 2005 and 2014 were retrospectively analyzed. After excluding patients <18 years old, patients without stenting, and patients who underwent multiorgan transplantation, a total of 308 patients were included in the study. Two consecutive cohorts of patients were compared. In the cohort transplanted between 2005 and 2010, stenting was routinely performed using PS (216 patients), and in the second cohort, those transplanted after 2011, stenting was routinely performed using JJS (92 patients). For ureteric anastomosis, the Lich-Grégoir technique was used in all patients. RESULTS: There was no statistical difference in postoperative urinary tract infections (P = .239) between the 2 cohorts. In patients with PS, the incidence of major urologic complications (11.6% vs 3.3%; P = .018), vesicoureteral reflux (14.3% vs 2.2%; P < .001), and urologic reinterventions (14.4% vs 5.4%; P = .031) was significantly higher when compared with JJS patients. Multivariable logistic regression revealed increased incidence of major urologic complications (odds ratio [OR] 3.66, 95% confidence interval [CI] 1.07-12.55, P = .039) and vesicoureteral reflux (OR 5.29, 95% CI 1.21-23.10, P = .027) in patients with PS compared with JJS. CONCLUSION: Stenting of ureterovesical anastomosis using JJS is associated with reduced complications compared with PS after kidney transplantation.
Asunto(s)
Trasplante de Riñón/métodos , Complicaciones Posoperatorias/epidemiología , Stents/efectos adversos , Uréter/cirugía , Adolescente , Adulto , Anastomosis Quirúrgica/instrumentación , Anastomosis Quirúrgica/métodos , Femenino , Humanos , Incidencia , Trasplante de Riñón/efectos adversos , Trasplante de Riñón/instrumentación , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/etiología , Estudios Retrospectivos , Infecciones Urinarias/epidemiología , Infecciones Urinarias/etiología , Reflujo Vesicoureteral/epidemiología , Reflujo Vesicoureteral/etiologíaRESUMEN
Abstract We describe an unusual case of hyperacute hepatic failure following general anesthesia in a patient receiving a simultaneous kidney-pancreas transplant. Despite an aggressive evaluation of structural, immunological, viral, and toxicological causes, a definitive cause could not be elucidated. The patient required a liver transplant and suffered a protracted hospital course. We discuss the potential causes of fulminant hepatic failure and the perioperative anesthesia management of her subsequent liver transplantation.
Resumo Descrevemos um caso incomum de insuficiência hepática hiperaguda após a anestesia geral em uma paciente que recebeu um transplante simultâneo de rim-pâncreas. Apesar de uma avaliação agressiva das causas estruturais, imunológicas, virais e toxicológicas, uma causa definitiva não pôde ser identificada. A paciente precisou de um transplante de fígado que resultou em prolongamento da internação hospitalar. Discutimos as potenciais causas da insuficiência hepática fulminante e o manejo da anestesia no período perioperatório de seu subsequente transplante de fígado.
Asunto(s)
Humanos , Trasplante de Riñón/instrumentación , Trasplante de Hígado/instrumentación , Anestésicos por Inhalación/administración & dosificación , Insuficiencia Hepática/cirugía , Isoflurano/efectos adversosRESUMEN
BACKGROUND: Kidney transplantation remains the best therapeutic option for chronic renal failure. The objective of the study was to evaluate the impact of ureteral duplication in donor kidneys on transplantation outcome. METHODS: In this study we performed a retrospective analysis of 75 patients who had undergone renal transplantation. The evaluated parameters included frequency of occurrence and risk of reoperation and graftectomy, mortality, as well as dependency of early and long-term graft function on pyelocaliceal system duplication. RESULTS: Ureteral duplication was associated with more frequent double J stent catheter implantation (P < .05). There was no relationship detected between ureteral duplication, number of operations performed, and risk of graftectomy (P > .05). Early graft function with 2 ureters was similar to that of grafts with a single pyelocaliceal system. The long-term results were also comparable. CONCLUSION: Ureteral duplication should not be considered a contraindication for renal transplantation.
Asunto(s)
Fallo Renal Crónico/cirugía , Trasplante de Riñón/efectos adversos , Stents , Uréter/anomalías , Adulto , Humanos , Trasplante de Riñón/instrumentación , Trasplante de Riñón/métodos , Masculino , Persona de Mediana Edad , Reoperación/estadística & datos numéricos , Estudios Retrospectivos , Resultado del Tratamiento , Uréter/cirugía , Ureterostomía/efectos adversos , Ureterostomía/instrumentación , Ureterostomía/métodosAsunto(s)
Fallo Renal Crónico/terapia , Riñones Artificiales , Animales , Investigación Biomédica , Diseño de Equipo , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Fallo Renal Crónico/historia , Trasplante de Riñón/historia , Trasplante de Riñón/instrumentación , Trasplante de Riñón/métodos , Riñones Artificiales/historia , Países Bajos , Diálisis Renal/historia , Diálisis Renal/instrumentación , Diálisis Renal/métodosRESUMEN
Robotic-assisted kidney transplantation (RAKT) offers key benefits for patients that have been demonstrated in several studies. A barrier to the wider uptake of RAKT is surgical skill acquisition. This is exacerbated by the challenges of modern surgery with reduced surgical training time, patient safety concerns and financial pressures. Simulation is a well-established method of developing surgical skill in a safe and controlled environment away from the patient. We have developed a 3D printed simulation model for the key step of the kidney transplant operation which is the vascular anastomosis. The model is anatomically accurate, based on the CT scans of patients and it incorporates deceased donor vascular tissue. Crucially, it was developed to be used in the robotic operating theatre with the operating robot to enhance its fidelity. It is portable and relatively inexpensive when compared with other forms of simulation such as virtual reality or animal lab training. It thus has the potential of being more accessible as a training tool for the safe acquisition of RAKT specific skills. We demonstrate this model here.
Asunto(s)
Trasplante de Riñón/instrumentación , Modelos Anatómicos , Impresión Tridimensional , Procedimientos Quirúrgicos Robotizados/instrumentación , Diseño de Equipo , Humanos , Trasplante de Riñón/métodos , Procedimientos Quirúrgicos Robotizados/métodosAsunto(s)
Fallo Renal Crónico/cirugía , Trasplante de Riñón/métodos , Riñón/irrigación sanguínea , Perfusión/métodos , Arteria Renal/cirugía , Humanos , Riñón/cirugía , Trasplante de Riñón/efectos adversos , Trasplante de Riñón/instrumentación , Perfusión/efectos adversos , Perfusión/instrumentaciónRESUMEN
OBJECTIVES: The aim of this study was to evaluate the effects of 2 types of external ureteral stents on the number of urological complications after kidney transplant. MATERIALS AND METHODS: Data were retrospectively collected from 366 consecutive transplants performed between January 2013 and January 2015 in our hospital, in which an external ureteral stent was placed during surgery and removed after 9 days. Urological complications were defined as urinary leakage or ureteral stenosis requiring percutaneous nephrostomy placement. RESULTS: A total of 197 patients received a straight stent with 2 larger side holes (type A; 8F "Covidien" tube; Covidien, Dublin, Ireland) and 169 patients received a single J stent with 7 smaller side holes (type B; 7F "Teleflex" single J stent; Teleflex Medical, Athlone, Ireland). We found a significantly higher number of percutaneous nephrostomy placements with type A stents, with 34 (17%) versus 16 (9%) in type B (P = .030). Reason for percutaneous nephrostomy placement, occurrence of stent dysfunction, and need for early removal (< 8 days) were equal in both groups (P = .397), whereas incidence of rejection and urinary tract infection were higher in type B stent group. Patient and graft survival did not differ between the groups. CONCLUSIONS: Use of the type B stent was associated with less urological complications compared with the type A stent.
Asunto(s)
Trasplante de Riñón/instrumentación , Stents , Uréter/cirugía , Obstrucción Ureteral/prevención & control , Incontinencia Urinaria/prevención & control , Adulto , Anciano , Femenino , Rechazo de Injerto/etiología , Rechazo de Injerto/prevención & control , Supervivencia de Injerto , Humanos , Trasplante de Riñón/efectos adversos , Trasplante de Riñón/métodos , Masculino , Persona de Mediana Edad , Nefrostomía Percutánea , Diseño de Prótesis , Estudios Retrospectivos , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento , Obstrucción Ureteral/diagnóstico , Obstrucción Ureteral/etiología , Incontinencia Urinaria/diagnóstico , Incontinencia Urinaria/etiología , Infecciones Urinarias/etiología , Infecciones Urinarias/prevención & controlRESUMEN
OBJETIVO: Las complicaciones urológicos mayores, fístulas y estenosis, afectan principalmente a la anastomosis vesico-ureteral y se presentan en el periodo temprano post-trasplante (TR). El empleo sistemático de catéteres ureterales continúa siendo controvertido con muchos grupos utilizándolos sólo de forma selectiva en función de la existencia de factores de riesgo pretrasplante o intraoperatorios. MÉTODOS: Se llevó a cabo una revisión de la literatura mediante la búsqueda automatizada en las bases de datos bibliográficas Medline como fuente bibliográfica principal y en Clinical Key. La estrategia de búsqueda incluyó los siguientes términos: 'stent' AND 'kidney transplantation'. RESULTADOS: La revisión de la literatura puso de manifiesto el efecto protector del empleo de catéteres ureterales en la ureteroneocistostomía del TR tanto para el desarrollo de fístulas (RR 0,29, 0,12 a 0,74, p=0,009) como de estenosis (RR 0,27, 0,09 a 0,81, p=0,02). El empleo de catéteres en pacientes inmunodeprimidos se asoció a un incremento significativo en la incidencia de ITUs post-TR (RR 1,49 IC 95% 1,04 a 2,15, p=0,03) que fue prevenida por la profilaxis antibiótica dirigida a la neumonía por pneumocistis carinii con cotrimoxazol. Las tasas de permeabilidad de los stent metálicos autoexpandibles y los by-pass extra-anatómicos en el tratamiento de la estenosis ureteral post-TR en pacientes de alto riesgo quirúrgico o tras el fracaso previo de la cirugía, con un número limitado de pacientes incluidos, ha variado entre el 50% y el 100%. CONCLUSIONES: El empleo de un catéter ureteral en la ureteroneocistostomía extravesical disminuye la incidencia de complicaciones anastomóticas. El tratamiento de elección de la estenosis ureteral post-TR es el tratamiento quirúrgico. El uso de stents metálicos y by-pass extraanatómicos debe limitarse al tratamiento de estenosis ureterales complejas en las que ha fallado el tratamiento primario, pacientes con elevado riesgo quirúrgico o disfunción crónica del injerto
OBJECTIVE: Mayor urological complications, fistulae and stenosis, mainly affect the vesicoureteral anastomosis and present in the early post-transplant period. The systematic use of ureteral catheters keeps selecbeing controversial with many groups using them only selectively depending on the existence of pretransplant or intraoperative risk factors. METHODS: We performed a bibliographic review through automatized search in the Medline bibliographic database, as the main bibliographic source, and also in Clinical Key. The search strategy included the following terms: 'stent' AND 'kidney transplantation'. RESULTS: The bibliographic search revealed the protective effect of the use of ureteral catheters in the transplant ureteroneocystostomy for both development of fistulae (RR 0.29, 0.12 to 0.74, p = 0.009) and stenosis (RR 0.27, 0.09 to 0.81, p = 0.02). The use of catheters in immunosuppressed patients was associated with significant increase of the incidence of post-transplant urinary tract infections (RR 1.49 IC 95% 1.04 to 2.15, p = 0.03) that was prevented by antibiotic prophylaxis with cotrimoxazole directed against pneumocistis carinii. The rates of permeability of self-expandable metallic stents and extra-anatomic bypasses in the treatment of ureteral stenosis after renal transplantation in high surgical risk patients or after the failure of previous surgery, has varied from 50% to 100%, with a limited number of patients included. CONCLUSIONS: The use of ureteral catheters in the extravesical ureteroneocystostomy reduces the incidence of anastomotic complications. Surgery is the treatment of choice of post-transplant ureteral stenosis. The use of metallic stents and extra-anatomic bypasses should be limited to complex ureteral stenosis when primary therapy has failed, in high surgical risk patients or chronic graft dysfunction